4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-013691
Director acquired 4,350 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2024-07-01 | Other acquisition 10b5-1 | +221 | $1.47 | $325 | 243,778 | D: show line 1 in the form |
| Krogulski Kenneth Director | 2024-07-02 | Other acquisition 10b5-1 | +221 | $1.48 | $327 | 243,999 | D: show line 2 in the form |
| Krogulski Kenneth Director | 2024-07-03 | Other acquisition 10b5-1 | +268 | $1.52 | $407 | 244,267 | D: show line 3 in the form |
| Krogulski Kenneth Director | 2024-07-05 | Other acquisition 10b5-1 | +221 | $1.50 | $332 | 244,488 | D: show line 4 in the form |
| Krogulski Kenneth Director | 2024-07-08 | Other acquisition 10b5-1 | +221 | $1.49 | $329 | 244,709 | D: show line 5 in the form |
| Krogulski Kenneth Director | 2024-07-09 | Other acquisition 10b5-1 | +221 | $1.50 | $332 | 244,930 | D: show line 6 in the form |
| Krogulski Kenneth Director | 2024-07-10 | Other acquisition 10b5-1 | +221 | $1.50 | $332 | 245,151 | D: show line 7 in the form |
| Krogulski Kenneth Director | 2024-07-11 | Other acquisition 10b5-1 | +221 | $1.47 | $325 | 245,372 | D: show line 8 in the form |
Loading xslF345X05/marketforms-66717.xml…